Start Codon aims to rapidly translate the most disruptive and innovative life science research into successful companies and positive clinical outcomes The first cohort of four companies will debut at ...

CAMBRIDGE, England--(BUSINESS WIRE)--Start Codon, a new strategic initiative aimed at driving the translation of world-class research into commercially successful companies, has been founded and ...

Start Codon, a new model of life science and healthcare business accelerator, today announced it has partnered with One Nucleus, a membership organisation for life science and healthcare companies.

In a new study, researchers at the University of Oregon's Phil and Penny Knight Campus for Accelerating Scientific Impact used start codon disruption with CRISPR-Cas9 gene editing to prevent Fuchs' ...

Start Codon, a new model of life science and healthcare business accelerator, has announced two appointments to its senior team. Founded earlier this year, Start Codon is a strategic initiative, which ...

Scientists at deCODE genetics, a subsidiary of Amgen, have published a study in Nature Communications, comparing over 110 thousand patients with autoimmune thyroid disease (AITD) from Iceland, Finland ...

LONDON – As the birthplace of European biotechnology, Cambridge, U.K., should surely have all the money and services it takes to start up and grow companies. But it seems there is a gap in the market, ...

Plasmids containing a mouse cDNA sequence encoding the enzyme dihydrofolate reductase (DHFR; tetrahydrofolate dehydrogenase; 5,6,7,8-tetrahydrofolate:NADP + oxidoreductase, EC 1.5.1.3) have been used ...